TIBET PHARMACEUTIC COM USD0.001 (TBET)

0.00
OTC Markets
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange OTC Markets
Shares Outstanding 14.85B
Market Cap 3.00K
Div & Yield N.A. (N.A)

Latest News

5 Stocks Rising on Monster Volume

5 Stocks Rising on Monster Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

5 Worst IPOs of 2011

5 Worst IPOs of 2011

The average IPO is down 12% in 2011.

Tibet Pharmaceuticals Announces Availability Of Third Quarter 2011 Earnings Call Transcript

Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today announced the ...

Tibet Pharmaceuticals Reports Financial Results For Third Quarter Ended September 30, 2011

Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today reported its financial...

Tibet Pharmaceuticals To Host Third Quarter 2011 Earnings Conference Call On November 15, 2011, At 9:00 A.m. Eastern

Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, will host a conference call on...

Tibet Pharmaceuticals Announces Appointment Of Sherb & Co., LLP As New Independent Auditor

Sherb & Co. to Commence its Work Immediately with the Review of the Company's Upcoming Q3 2011 Financial Statements

Tibet Pharmaceuticals Announces Search For New Auditor Upon Resignation Of ACSB

ACSB Resigns Tibet's Account as Auditor Pulls Out of China; Resignation Involved No Disagreements, Adverse Opinion or Disclaimer of Opinion

Murphy Analytics Issues Updated Research Report On Tibet Pharmaceuticals

New Report Outlines Recent Developments, States that Tibet is Trading at Less than Cash Value

Tibet Pharmaceuticals Announces Availability Of Second Quarter 2011 Earnings Call Transcript

Management Discusses Tibet's Leading Products, Business Strategy and Recent Financial Performance

Tibet Pharmaceuticals Reports Financial Results For Second Quarter Ended June 30, 2011

Earnings Conference Call Scheduled for Tuesday, August 16 at 9:00 am Eastern

Tibet Pharmaceuticals To Host Second Quarter 2011 Earnings Conference Call On August 16, 2011 At 9:00 Am Eastern

Management Team to Discuss Tibet Pharmaceuticals' Financial Performance in the Second Quarter 2011, and Growth Potential in China's Expanding Traditional Medicine Market

Tibet Pharmaceuticals Announces New CEO

Tibet's Chairman, Hong Yu, Replaces Taylor Guo as CEO of Tibet Pharmaceuticals

Tibet Pharmaceuticals Announces Availability Of First Quarter 2011 Earnings Call Transcript

Management Team Discusses Tibet's Lead Products, Business Strategy and Recent Financial Performance

Tibet Pharmaceuticals Reports Financial Results For First Quarter Ended March 31, 2011

Earnings Conference Call Scheduled for Tuesday, May 17 at 9:30 am Eastern

Tibet Pharmaceuticals To Host First Quarter 2011 Earnings Conference Call On May 17, 2011 At 9:30 Am Eastern

Management Team to Discuss Tibet Pharmaceuticals' Financial Performance in the First Quarter 2011, and Growth Potential in China's Expanding Traditional Medicine Market

Tibet Pharmaceuticals Announces Availability Of A White Paper By SmallcapInsights.com

Paper Describes China's Traditional Tibetan Medicine Market and the Growth Opportunities in China's Expanding Healthcare Industry

Tibet Pharmaceuticals Announces Release Of Corporate Overview Video

Video Speaks to Tibet Pharmaceuticals' Specialty Medicines and Growth Opportunity in China's Expanding Healthcare Industry

Murphy Analytics Initiates Research Coverage On Tibet Pharmaceuticals

Detailed Report Targets 12-Month Price of $11.00

Tibet Pharmaceuticals Announces Availability Of Updated Investor Fact Sheet

Informative Resource Provides Investor-Oriented Company Overview and Detailed Description of Tibet Pharmaceuticals' Growth Initiatives

Tibet Pharmaceuticals Reports Record Financial Results For Fiscal Year Ended December 31, 2010

Revenue for Fiscal Year December 31 Increases 41% to $32.4 Million

Tibet Pharmaceuticals To Host FY 2010 Earnings Conference Call On April 1, 2011 At 10:00 Am Eastern

Management Team to Discuss Tibet Pharmaceuticals' Financial Performance in 2010, and Growth Potential in China's Expanding Traditional Chinese Medicine Market

Tibet Pharmaceuticals Announces Launch Of New Corporate Website

Website Provides New Resources for Investors, Including a Description of Tibet Pharmaceuticals' Business Model in China's Growing Traditional Tibetan Medicine Market

Tibet Pharmaceuticals Announces Availability Of New Online Investor Fact Sheet

Informative Resource Provides Investor-Oriented Company Overview and Detailed Description of Tibet Pharmaceuticals' Growth Initiatives